Skip to search formSkip to main contentSkip to account menu

NSC 95397

Known as: NSC95397 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Suppresses Proliferation and Induces Apoptosis in Colon Cancer Cells through MKP-1 and the ERK 1 / 2 Pathway
NSC 95397, a quinone-based small molecule compound, has been identified as an inhibitor for dual-specificity phosphatases… 
2015
2015
Abstract A44: S100A4 drives the invasive potential of non-small cell lung cancer cells and is targeted by FDA approved drugs
The metastatic nature of advanced non-small cell lung cancer (NSCLC), often associated with therapeutic resistance, accounts for… 
2008
2008
Microarray studies propose a new mechanism of action for NSC 95397
Cancer is a common disease and due to problems with resistance against cancer drugs and the limited benefit from chemotherapy in… 
2006
2006
Identification and evaluation of potential anti-cancer drugs on human neuroendocrine tumor cell lines.
UNLABELLED The aim of this study was to investigate drug sensitivity in neuroendocrine tumor cell lines. MATERIALS AND METHODS… 
2004
2004
NAD ( P ) H : Quinone Oxidoreductase-1-Dependent and-Independent Cytotoxicity of Potent Quinone Cdc 25 Phosphatase Inhibitors
Cdc25 dual-specificity phosphatases coordinate cell cycle progression and cellular signaling. Consequently, Cdc25 inhibitors… 
2004
2004
NAD(P)H:Quinone Oxidoreductase-1-Dependent and -Independent Cytotoxicity of Potent Quinone Cdc25 Phosphatase Inhibitors
Cdc25 dual-specificity phosphatases coordinate cell cycle progression and cellular signaling. Consequently, Cdc25 inhibitors… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)